1 completed, 1 not yet recruiting, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Not yet recruiting 1, Terminated 1 |
Follow Crohns Disease: new trials by email Literature Review of Crohns Disease trials Research Report on Crohns Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Efficacy and Safety of Mirikizumab in Adults Over 60 With Moderate to Severe Crohn's Disease and Ulcerative Colitis Mirikizumab - Crohn Disease (CD), Crohns Disease | Phase 4 | Not yet recruiting | Rubix LS | 150 | 2025-07-16 | 2025-07-10 |
| Pneumococcal Vaccination of Crohn Patients Prevenar 13, Pneumovax - Crohns Disease | Phase 4 | Completed | Statens Serum Institut | 151 | 2013-07-01 | 2015-02-10 |
| Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease Colesevelam, Placebo - Crohns Disease, Bile Acid Malabsorption | Phase 4 | Terminated | Florian Beigel | 34 | 2010-10-01 | 2013-04-18 |
Crohn Disease (3) · Colitis, Ulcerative (1)
Digestive System Diseases (3) · Gastroenteritis (3) · Gastrointestinal Diseases (3) · Inflammatory Bowel Diseases (3) · Intestinal Diseases (3) · Colitis (1) · Colonic Diseases (1)
13-valent pneumococcal vaccine (1) · Colesevelam Hydrochloride (1) · Pneumococcal Vaccines (1) · mirikizumab (1)
Florian Beigel (1) · Rubix LS (1) · Statens Serum Institut (1)
Denmark (1) · Germany (1) · United States (1)
Andreas M Petersen, MD (1) · Florian Beigel, M.D. (1)
PMID 24953836, PMID 26275480, PMID 31290715
2009 (1)